Preoperative and Postoperative Nutritional Support Methods For Pancreatic Cancer: A Review
DOI:
https://doi.org/10.61173/1xejtg19Keywords:
Pancreatic cancer, Malnutrition, Periopera-tive management, Nutritional intervention, CachexiaAbstract
Pancreatic cancer (PC) is a highly malignant neoplasm often detected at an advanced stage, resulting in a poor prognosis. Major risk factors include cigarette smoking, excessive alcohol consumption, obesity, and genetic predisposition. Malnutrition, cachexia, and sarcopenia are prevalent among PC patients and significantly impact clinical outcomes. Evidence suggests that perioperative nutritional interventions—ranging from early screening and assessment to oral supplementation, pancreatic enzyme replacement therapy, and enteral or parenteral nutrition—can alleviate postoperative complications, shorten hospital stays, and enhance quality of life. Early refeeding and stepwise dietary advancement are vital to maintaining gastrointestinal function and meeting energy requirements. In addition, continuing patient education and home-based nutritional management after discharge are crucial, as many patients remain at high risk of nutritional deficits postoperatively. Despite these benefits, standardized disease-specific guidelines for nutritional support in PC are still lacking, and further investigation is required to determine optimal strategies and timing for interventions. Multidisciplinary collaboration, involving surgeons, oncologists, and dietitians, is essential for addressing the multifaceted nutritional challenges encountered by PC patients and for improving both survival and quality of life. Future research should also focus on refining assessment tools, identifying specific biomarkers, and evaluating long-term outcomes to establish more targeted nutritional guidelines for PC care.
References
[1] Bray, F., Laversanne, M., Sung, H., Ferlay, J., Siegel, R. L., Soerjomataram, I., & Jemal, A. (2024). Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: a cancer journal for clinicians, 74(3), 229-263. https://doi.org/10.1016/ j.jand.2017.07.005
[2] Zhao, Z., & Liu, W. (2020). Pancreatic Cancer: A Review of Risk Factors, Diagnosis, and Treatment. Technology in cancer research & treatment, 19, 1533033820962117. https://doi. org/10.1177/1533033820962117
[3] McGuigan, A., Kelly, P., Turkington, R. C., Jones, C., Coleman, H. G., & McCain, R. S. (2018). Pancreatic cancer: A review of clinical diagnosis, epidemiology, treatment and outcomes. World journal of gastroenterology, 24(43), 4846–
[4861] https://doi.org/10.3748/wjg.v24.i43.4846
[4] Ilic, I., & Ilic, M. (2022). International patterns in incidence and mortality trends of pancreatic cancer in the last three decades: A joinpoint regression analysis. World journal of gastroenterology, 28(32), 4698–4715. https://doi.org/10.3748/ wjg.v28.i32.4698
[5] Mękal, D., Sobocki, J., Badowska-Kozakiewicz, A., Sygit, K., Cipora, E., Bandurska, E., Czerw, A., & Deptała, A. (2023). Evaluation of Nutritional Status and the Impact of Nutritional Treatment in Patients with Pancreatic Cancer. Cancers, 15(15),
[3816] https://doi.org/10.3390/cancers15153816
[6] Aoyama, T., Maezawa, Y., Hashimoto, I., Rino, Y., & Oshima, T. (2023). Clinical Impact of Nutrition and Inflammation Assessment Tools in Pancreatic Cancer Treatment. Anticancer research, 43(9), 3849–3860. https://doi.org/10.21873/ anticanres.16572
[7] Cañamares-Orbís, P., García-Rayado, G., & Alfaro-Almajano, E. (2022). Nutritional Support in Pancreatic Diseases. Nutrients, 14(21), 4570. https://doi.org/10.3390/nu14214570
[8] Klein, A. P. (2021). Pancreatic cancer epidemiology: understanding the role of lifestyle and inherited risk factors. Nature reviews. Gastroenterology & hepatology, 18(7), 493–502. https://doi.org/10.1038/s41575-021-00457-x
[9] Bosetti, C., Lucenteforte, E., Silverman, D. T., Petersen, G., Bracci, P. M., Ji, B. T., Negri, E., Li, D., Risch, H. A., Olson, S. H., Gallinger, S., Miller, A. B., Bueno-de-Mesquita, H. B., Talamini, R., Polesel, J., Ghadirian, P., Baghurst, P. A., Zatonski, W., Fontham, E., Bamlet, W. R., … La Vecchia, C. (2012). Cigarette smoking and pancreatic cancer: an analysis from the International Pancreatic Cancer Case-Control Consortium (Panc4). Annals of oncology, 23(7), 1880–1888. https://doi. org/10.1093/annonc/mdr541
[10] Naudin, S., Li, K., Jaouen, T., Assi, N., Kyrø, C., Tjønneland, A., Overvad, K., Boutron-Ruault, M. C., Rebours, V., Védié, A. L., Boeing, H., Kaaks, R., Katzke, V., Bamia, C., Naska, A., Trichopoulou, A., Berrino, F., Tagliabue, G., Palli, D., Panico, S., … Ferrari, P. (2018). Lifetime and baseline alcohol intakes and risk of pancreatic cancer in the European Prospective Investigation into Cancer and Nutrition study. International journal of cancer, 143(4), 801–812. https://doi.org/10.1002/ ijc.31367
[11] Li, D., Tang, H., Hassan, M. M., Holly, E. A., Bracci, P. M., & Silverman, D. T. (2011). Diabetes and risk of pancreatic cancer: a pooled analysis of three large case-control studies. Cancer causes & control, 22(2), 189–197. https://doi. org/10.1007/s10552-010-9686-3
[12] Wang, F., Herrington, M., Larsson, J., & Permert, J. (2003). The relationship between diabetes and pancreatic cancer. Molecular cancer, 2, 4. https://doi.org/10.1186/1476-4598-2-4
[13] Eibl, G., Cruz-Monserrate, Z., Korc, M., Petrov, M. S., Goodarzi, M. O., Fisher, W. E., Habtezion, A., Lugea, A., Pandol, Dean&Francis Terri Jinyi Tao S. J., Hart, P. A., Andersen, D. K., & Consortium for the Study of Chronic Pancreatitis, Diabetes, and Pancreatic Cancer (2018). Diabetes Mellitus and Obesity as Risk Factors for Pancreatic Cancer. Journal of the Academy of Nutrition and Dietetics, 118(4), 555–567. https://doi.org/10.1016/j.jand.2017.07.005
[14] Kuang, N. (2017, December). Tunnel Detection Robot. In 2017 7th International Conference on Mechatronics, Computer and Education Informationization (MCEI 2017) (pp. 665-670). Atlantis Press. https://doi.org/10.2991/mcei-17.2017.141
[15] Calle, E. E., Rodriguez, C., Walker-Thurmond, K., & Thun, M. J. (2003). Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. The New England journal of medicine, 348(17), 1625–1638. https://doi. org/10.1056/NEJMoa021423
[16] Cai, J., Chen, H., Lu, M., Zhang, Y., Lu, B., You, L., Zhang, T., Dai, M., & Zhao, Y. (2021). Advances in the epidemiology of pancreatic cancer: Trends, risk factors, screening, and prognosis. Cancer letters, 520, 1–11. https://doi.org/10.1016/ j.canlet.2021.06.027
[17] Chandana, S. R., Woods, L. M., Maxwell, F., Gandolfo, R., & Tanios Bekaii-Saab. (2023). Risk factors for early-onset pancreatic ductal adenocarcinoma: A systematic literature review. European Journal of Cancer, 198, 113471. https://doi. org/10.1016/j.ejca.2023.113471
[18] Hendifar, A. E., Petzel, M. Q. B., Zimmers, T. A., et al. (2019). Pancreas cancer-associated weight loss. The Oncologist, 24(5), 691–701. https://doi.org/10.1634/theoncologist.2018-0222
[19] Li, C. L., Gu, X. Y., Qian, L., et al. (2019). Multivariate analysis of prognosis in patients with pancreatic cancer. Journal of Nutritional Oncology, 4(2), 91–102. https://doi.org/10.1007/ s12094-021-02674-x
[20] Yeom, E., Shin, H., Yoo, W., et al. (2021). Tumor-derived Dilp8/Insl3 induces cancer anorexia by regulating feeding neuropeptides via Lgr3/8 in the brain. Nature Cell Biology, 23(2), 172–183. https://doi.org/10.1038/s41556-020-00615-3
[21] Poulia, K. A., Sarantis, P., Antoniadou, D., et al. (2020). Pancreatic cancer and cachexia—Metabolic mechanisms and novel insights. Nutrients, 12(6), 1543. https://doi.org/10.3390/ nu12061543
[22] Danai, L. V., Babic, A., Rosenthal, M. H., et al. (2018). Altered exocrine function can drive adipose wasting in early pancreatic cancer. Nature, 558(7711), 600–604. https://doi. org/10.1038/s41586-018-0235-7
[23] Vujasinovic, M., Valente, R., Del Chiaro, M., et al. (2017). Pancreatic exocrine insufficiency in pancreatic cancer. Nutrients, 9(3), 183. https://doi.org/10.3390/nu9030183
[24] Falconer, J. S., Fearon, K. C., Plester, C. E., et al. (1994). Cytokines, the acute-phase response, and resting energy expenditure in cachectic patients with pancreatic cancer. Annals of Surgery, 219(4), 325–331. https://doi.org/10.1097/00000658- 199404000-00003
[25] Purcell, S. A., Wallengren, O., Baracos, V. E., et al. (2020). Determinants of change in resting energy expenditure in patients with stage III/IV colorectal cancer. Clinical Nutrition, 39(1), 134–140. https://doi.org/10.1016/j.clnu.2019.01.024
[26] Barcellos, P. S., Borges, N., & Torres, D. P. M. (2021). Resting energy expenditure in cancer patients: Agreement between predictive equations and indirect calorimetry. Clinical Nutrition ESPEN, 42, 286–291. https://doi.org/10.1016/ j.clnesp.2021.02.007
[27] Kuang, N. (2017, December). Blade Detection Robot. In 2017 7th International Conference on Mechatronics, Computer and Education Informationization (MCEI 2017) (pp. 317-321). Atlantis Press. https://doi.org/10.2991/mcei-17.2017.69
[28] Woo, S. M., Joo, J., Kim, S. Y., et al. (2016). Efficacy of pancreatic exocrine replacement therapy for patients with unresectable pancreatic cancer in a randomized trial. Pancreatology, 16(6), 1099–1105. https://doi.org/10.1016/ j.pan.2016.10.002
[29] Arends, J., Bachmann, P., Baracos, V., Barthelemy, N., Bertz, H., Bozzetti, F., Fearon, K., & Hütterer, E. (2016). ESPEN guidelines on nutrition in cancer patients. Clinical Nutrition, 36(1), 11–48. https://doi.org/10.1016/j.clnu.2016.07.015
[30] Carrato, A., Cerezo, L., Feliu, J., Macarulla, T., Martín- Pérez, E., Vera, R., Álvarez, J., & Botella-Carretero, J. I. (2021). Clinical nutrition as part of the treatment pathway of pancreatic cancer patients: an expert consensus. Clinical and Translational Oncology, 24(1), 112–126. https://doi.org/10.1007/s12094-021- 02674-x
[31] BAPEN. (2023, October 25). Enteral and Parenteral Nutrition | BAPEN. BAPEN. https://www.bapen.org.uk/ education/nutrition-support/assessment-planning/enteral-andparenteral-nutrition/
[32] Emanuel, A., Krampitz, J., Rosenberger, F., Kind, S., & Rötzer, I. (2022). Nutritional Interventions in Pancreatic Cancer: A Systematic Review. Cancers, 14(9), 2212. https://doi. org/10.3390/cancers14092212
[33] Loveday, B. P. T., Lipton, L., & Thomson, B. N. (2019). Pancreatic cancer: An update on diagnosis and management. Australian journal of general practice, 48(12), 826–831. https:// doi.org/10.31128/AJGP-06-19-4957
[34] ASPEN | What Is Parenteral Nutrition? (2024). Nutritioncare. org. https://www.nutritioncare.org/About_Clinical_Nutrition/ What_Is_Parenteral_Nutrition_/
[35] Chou, Y. J., Liou, Y. T., Lai, S. R., Tien, Y. W., Kuo, H. J., Yang, H. Y., & Shun, S. C. (2023). Role of preoperative malnutrition and symptom severity in anorexia-cachexia-related quality of life in patients with operable pancreatic cancer. European journal of oncology nursing, 66, 102352. https://doi. org/10.1016/j.ejon.2023.102352
[36] Lee, B., Han, H., Yoon, Y., Cho, J. Y., & Lee, J. S. (2020). Impact of preoperative malnutrition, based on albumin level and body mass index, on operative outcomes in patients with pancreatic head cancer. Journal of Hepato-Biliary-Pancreatic Dean&Francis ISSN 2959-409X Sciences, 28(12), 1069–1075. https://doi.org/10.1002/jhbp.858
[37] Deftereos, I., Yeung, J. M., Arslan, J., Carter, V. M., Isenring, E., Kiss, N., & On Behalf Of The Nourish Point Prevalence Study Group (2021). Preoperative Nutrition Intervention in Patients Undergoing Resection for Upper Gastrointestinal Cancer: Results from the Multi-Centre NOURISH Point Prevalence Study. Nutrients, 13(9), 3205. https://doi. org/10.3390/nu13093205
[38] Luo, W., Xu, Y., & Han, W. (2023). Research Status and Progress of Perioperative Nutritional Support in Pancreatic Cancer Patients. Advances in Clinical Medicine, 13(10), 15780– 15785. https://doi.org/10.12677/acm.2023.13102206
[39] Barber, M. D., Ross, J. A., Voss, A. C., Tisdale, M. J., & Fearon, K. C. (1999). The effect of an oral nutritional supplement enriched with fish oil on weight-loss in patients with pancreatic cancer. British journal of cancer, 81(1), 80–86. https://doi.org/10.1038/sj.bjc.6690654
[40] Cencioni, C., Trestini, I., Piro, G., Bria, E., Tortora, G., Carbone, C., & Spallotta, F. (2022). Gastrointestinal Cancer Patient Nutritional Management: From Specific Needs to Novel Epigenetic Dietary Approaches. Nutrients, 14(8), 1542. https:// doi.org/10.3390/nu14081542
[41] Kuang, N., Liu, Z., Yu, G., Wu, X., Becker, B., Fan, H., ... & Zhang, J. (2023). Neurodevelopmental risk and adaptation as a model for comorbidity among internalizing and externalizing disorders: genomics and cell-specific expression enriched morphometric study. BMC medicine, 21(1), 291. https://doi. org/10.1186/s12916-023-02920-9
[42] Jiang, Y., Wang, J., Zhou, E., Palaniyappan, L., Luo, C., Ji, G., ... & ZIB Consortium. (2023). Neuroimaging biomarkers define neurophysiological subtypes with distinct trajectories in schizophrenia. Nature Mental Health, 1(3), 186–199. https://doi. org/10.1038/s44220-023-00024-0
[43] Fan, H., Liu, Z., Wu, X., Yu, G., Gu, X., Kuang, N., ... & Zhang, J. (2023). Decoding anxiety–impulsivity subtypes in preadolescent internalising disorders: findings from the Adolescent Brain Cognitive Development study. The British Journal of Psychiatry, 223(6), 542–554. https://doi.org/10.1192/ bjp.2023.107
[44] Yu, G., Wu, X., Liu, Z., Shi, M., Fan, H., Liu, Y., ... & Zhang, J. (2023). Dose-Response Relationships between Physical Exercises and Mental Health during Early Adolescence: an Investigation of the Underlying Neural and Genetic Mechanisms from the ABCD Study. medRxiv, 2023-09. https:// doi.org/10.1101/2023.09.20.23295830
[45] Yu, G., Wu, X., Liu, Z., Becker, B., Kuang, N., Kang, J., ... & Zhang, J. (2021). Common and disorders-specific cortical thickness alterations in internalizing, externalizing and thought disorders in the preadolescents of the ABCD study. medRxiv, 2021-09. https://doi.org/10.1503/jpn.220202
[46] Zhang, J., Wu, X., Zhang, K., Kuang, N., Kong, X. Z., Cao, M., ... & Palaniyappan, L. (2024). Pre-adolescent Brain Asymmetry: Developmental Trajectory, Cognitive and Psychiatric Effects, Neurobiological and Environmental Influences in ABCD Study. https://doi.org/10.21203/ rs.3.rs-5253313/v1
[47] Funk Debleds, P., Chambrier, C., & Slim, K. (2024). Postoperative nutrition in the setting of enhanced recovery programmes. European Journal of Surgical Oncology, 50(5), 106866. https://doi.org/10.1016/j.ejso.2023.03.006
[48] Lassen, K., Marielle, Slim, K., Carli, F., de, E., Schäfer, M., Parks, R. W., Kenneth, Lobo, D. N., Demartines, N., Braga, M., Olle Ljungqvist, & Cornelis. (2012). Guidelines for Perioperative Care for Pancreaticoduodenectomy: Enhanced Recovery After Surgery (ERAS®) Society Recommendations. World Journal of Surgery, 37(2), 240–258. https://doi.org/10.1007/s00268-012- 1771-1
[49] DiMagno, E. P., Malagelada, J. R., Go, V. L., & Moertel, C. G. (1977). Fate of orally ingested enzymes in pancreatic insufficiency. Comparison of two dosage schedules. The New England journal of medicine, 296(23), 1318–1322. https://doi. org/10.1056/NEJM197706092962304
[50] Pongprasobchai, S. (2013). Maldigestion from pancreatic exocrine insufficiency. Journal of gastroenterology and hepatology, 28 Suppl 4, 99–102. https://doi.org/10.1111/ jgh.12406
[51] Akashi, Y., Hiki, N., Nunobe, S., Jiang, X., & Yamaguchi, T.
[2012] . Safe management of anastomotic leakage after gastric cancer surgery with enteral nutrition via a nasointestinal tube. Langenbeck’s archives of surgery, 397(5), 737–744. https://doi. org/10.1007/s00423-012-0935-7
[52] Tabriz, N., Uslar, V. N., Obonyo, D., & Weyhe, D.
[2021] . Micronutritional status after pylorus preserving duodenopancreatectomy: analysis of data from a randomized controlled trial. Scientific Reports, 11(1). https://doi.org/10.1038/ s41598-021-97438-6
Downloads
Published
Issue
Section
License
Copyright (c) 2025 by the authors.
This work is licensed under a Creative Commons Attribution 4.0 International License.
